Novel Agents Under Investigation for Multiple Myeloma

Video

Oncologists highlight novel agents currently being investigated for the treatment of relapsed/refractory multiple myeloma.

Recent Videos
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
Related Content